The North America Glucosamine Market would witness market growth of 4.0% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 16,258.23 Tonnes, showcasing a growth of 3.2% (2019-2022).
One of the primary drivers behind the adoption of glucosamine is the aging population. As individuals age, the natural production of it in the body decreases, leading to joint-related issues. Older people, therefore, form a significant consumer base for these supplements, viewing them as a proactive measure to maintain joint health and alleviate symptoms associated with conditions like osteoarthritis. The adoption of this extends beyond older people to encompass individuals leading active lifestyles, including athletes and fitness enthusiasts.
The growing focus on health and wellness has propelled the adoption of dietary supplements, with glucosamine positioned as a natural and effective solution for joint health. Consumers, driven by a desire for preventive healthcare, are increasingly seeking products that contribute to overall well-being, and it fits seamlessly into this narrative. Educational campaigns have significantly influenced the adoption of this. Manufacturers and health organizations have invested in spreading awareness about the benefits of these through various channels, including social media, health blogs, and partnerships with healthcare professionals.
Osteoarthritis is one of the most prevalent degenerative joint diseases in the U.S. The U.S. population participates in various physical activities and sports, increasing the risk of joint wear and tear. Consumers in the U.S. often prefer natural solutions for health issues. The U.S. has a diverse population with varying dietary preferences and health needs. These products are widely available through online retail channels in the U.S. Growing trends toward holistic wellness influence consumer choices in the U.S. This is increasingly incorporated into sports nutrition products for joint support in the U.S. Therefore, the factors mentioned above will drive the regional market growth.
The US market dominated the North America Glucosamine Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $211.8 Million by 2030. The Canada market is experiencing a CAGR of 6.3% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.4% during (2023 - 2030).
Based on Application, the market is segmented into Supplement, Food & Beverage, and Others. Based on Product, the market is segmented into Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
One of the primary drivers behind the adoption of glucosamine is the aging population. As individuals age, the natural production of it in the body decreases, leading to joint-related issues. Older people, therefore, form a significant consumer base for these supplements, viewing them as a proactive measure to maintain joint health and alleviate symptoms associated with conditions like osteoarthritis. The adoption of this extends beyond older people to encompass individuals leading active lifestyles, including athletes and fitness enthusiasts.
The growing focus on health and wellness has propelled the adoption of dietary supplements, with glucosamine positioned as a natural and effective solution for joint health. Consumers, driven by a desire for preventive healthcare, are increasingly seeking products that contribute to overall well-being, and it fits seamlessly into this narrative. Educational campaigns have significantly influenced the adoption of this. Manufacturers and health organizations have invested in spreading awareness about the benefits of these through various channels, including social media, health blogs, and partnerships with healthcare professionals.
Osteoarthritis is one of the most prevalent degenerative joint diseases in the U.S. The U.S. population participates in various physical activities and sports, increasing the risk of joint wear and tear. Consumers in the U.S. often prefer natural solutions for health issues. The U.S. has a diverse population with varying dietary preferences and health needs. These products are widely available through online retail channels in the U.S. Growing trends toward holistic wellness influence consumer choices in the U.S. This is increasingly incorporated into sports nutrition products for joint support in the U.S. Therefore, the factors mentioned above will drive the regional market growth.
The US market dominated the North America Glucosamine Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $211.8 Million by 2030. The Canada market is experiencing a CAGR of 6.3% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.4% during (2023 - 2030).
Based on Application, the market is segmented into Supplement, Food & Beverage, and Others. Based on Product, the market is segmented into Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Teva Pharmaceutical Industries Ltd.
- Laboratoires Expanscience S.A.
- Nutramax Laboratories, Inc.
- Amway Corporation
- CellMark AB
- Alfa Chemical Group
- Cargill, Incorporated
- Simply Supplements
- Reckitt Benckiser Group PLC
- Panvo Organics Pvt Ltd.
Market Report Segmentation
By Application (Volume, Tonnes, USD Billion, 2019-2030)- Supplement
- Food & Beverage
- Others
- Glucosamine Sulfate
- Glucosamine Hydrochloride
- N-acetyl Glucosamine
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Glucosamine Market by Application
Chapter 5. North America Glucosamine Market by Product
Chapter 6. North America Glucosamine Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Teva Pharmaceutical Industries Ltd.
- Laboratoires Expanscience S.A.
- Nutramax Laboratories, Inc.
- Amway Corporation
- CellMark AB
- Alfa Chemical Group
- Cargill, Incorporated
- Simply Supplements
- Reckitt Benckiser Group PLC
- Panvo Organics Pvt Ltd.
Methodology
LOADING...
